Skip to main content

Our stories of impact

New study reveals breast cancer drug combination has impact on other cancers

4 Mar 2024
Photo: Professor Roisin Connolly, Director of Cancer Research at University College Cork.
  • Drug commonly used to treat HER2-positive breast cancer sees tumour shrinkage in several other cancer types.
  • Cancer treatment combination may have more uses than previously thought.

College of Medicine and Health Research & Innovation

Coláiste an Leighis agus na Sláinte Taighde agus Nuálaíocht

3rd Floor, Erinville Hospital, Western Road, University College Cork, T12 EKDO

Top